Cargando…
Long-term outcome of thyroid abnormalities in patients with severe Covid-19
OBJECTIVE: We have previously observed thyroid dysfunction, i.e. atypical thyroiditis (painless thyrotoxicosis associated with non-thyroidal illness syndrome), in patients with severe acute respiratory syndrome coronavirus 2 disease (Covid-19). This study aimed to analyse the evolution of thyroid dy...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083670/ https://www.ncbi.nlm.nih.gov/pubmed/36715690 http://dx.doi.org/10.1530/ETJ-22-0200 |
_version_ | 1785021577736224768 |
---|---|
author | Muller, Ilaria Daturi, Anita Varallo, Matteo Re, Tiziana E Dazzi, Davide Maioli, Sara Crivicich, Erica Di Marco, Francesco Longari, Virgilio Dazzi, Beatrice Castellani, Massimo Mantovani, Giovanna Arosio, Maura Salvi, Mario |
author_facet | Muller, Ilaria Daturi, Anita Varallo, Matteo Re, Tiziana E Dazzi, Davide Maioli, Sara Crivicich, Erica Di Marco, Francesco Longari, Virgilio Dazzi, Beatrice Castellani, Massimo Mantovani, Giovanna Arosio, Maura Salvi, Mario |
author_sort | Muller, Ilaria |
collection | PubMed |
description | OBJECTIVE: We have previously observed thyroid dysfunction, i.e. atypical thyroiditis (painless thyrotoxicosis associated with non-thyroidal illness syndrome), in patients with severe acute respiratory syndrome coronavirus 2 disease (Covid-19). This study aimed to analyse the evolution of thyroid dysfunction over time. METHODS: One hundred eighty-three consecutive patients hospitalised for severe Covid-19 without known thyroid history were studied at hospital admission (baseline). Survivors were offered 12-month longitudinal follow-up including assessment of thyroid function, autoantibodies and ultrasound scan (US). Patients showing US focal hypoechoic areas suggestive of thyroiditis (focal hypoechogenicity) also underwent thyroid (99m)Tc or (123)I uptake scan. RESULTS: At baseline, after excluding from TSH analysis, 63 out of 183 (34%) Covid-19 patients commenced on steroids before hospitalisation, and 12 (10%) showed atypical thyroiditis. Follow-up of 75 patients showed normalisation of thyroid function and inflammatory markers and no increased prevalence of detectable thyroid autoantibodies. Baseline US (available in 65 patients) showed focal hypoechogenicity in 28% of patients, of whom 82% had reduced thyroid (99m)Tc/(123)I uptake. The presence of focal hypoechogenicity was associated with baseline low TSH (P = 0.034), high free-thyroxine (FT4) (P = 0.018) and high interleukin-6 (IL6) (P = 0.016). Focal hypoechogenicity persisted after 6 and 12 months in 87% and 50% patients, respectively, but reduced in size. After 9 months, thyroid (99m)Tc/(123)I uptake partially recovered from baseline (+28%) but was still reduced in 67% patients. CONCLUSIONS: Severe Covid-19 induces mild transient thyroid dysfunction correlating with disease severity. Focal hypoechogenicity, associated with baseline high FT4, IL6 and low TSH, does not seem to be related to thyroid autoimmunity and may persist after 1 year although decreasing in size. Long-term consequences seem unlikely. |
format | Online Article Text |
id | pubmed-10083670 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Bioscientifica Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-100836702023-04-11 Long-term outcome of thyroid abnormalities in patients with severe Covid-19 Muller, Ilaria Daturi, Anita Varallo, Matteo Re, Tiziana E Dazzi, Davide Maioli, Sara Crivicich, Erica Di Marco, Francesco Longari, Virgilio Dazzi, Beatrice Castellani, Massimo Mantovani, Giovanna Arosio, Maura Salvi, Mario Eur Thyroid J Research OBJECTIVE: We have previously observed thyroid dysfunction, i.e. atypical thyroiditis (painless thyrotoxicosis associated with non-thyroidal illness syndrome), in patients with severe acute respiratory syndrome coronavirus 2 disease (Covid-19). This study aimed to analyse the evolution of thyroid dysfunction over time. METHODS: One hundred eighty-three consecutive patients hospitalised for severe Covid-19 without known thyroid history were studied at hospital admission (baseline). Survivors were offered 12-month longitudinal follow-up including assessment of thyroid function, autoantibodies and ultrasound scan (US). Patients showing US focal hypoechoic areas suggestive of thyroiditis (focal hypoechogenicity) also underwent thyroid (99m)Tc or (123)I uptake scan. RESULTS: At baseline, after excluding from TSH analysis, 63 out of 183 (34%) Covid-19 patients commenced on steroids before hospitalisation, and 12 (10%) showed atypical thyroiditis. Follow-up of 75 patients showed normalisation of thyroid function and inflammatory markers and no increased prevalence of detectable thyroid autoantibodies. Baseline US (available in 65 patients) showed focal hypoechogenicity in 28% of patients, of whom 82% had reduced thyroid (99m)Tc/(123)I uptake. The presence of focal hypoechogenicity was associated with baseline low TSH (P = 0.034), high free-thyroxine (FT4) (P = 0.018) and high interleukin-6 (IL6) (P = 0.016). Focal hypoechogenicity persisted after 6 and 12 months in 87% and 50% patients, respectively, but reduced in size. After 9 months, thyroid (99m)Tc/(123)I uptake partially recovered from baseline (+28%) but was still reduced in 67% patients. CONCLUSIONS: Severe Covid-19 induces mild transient thyroid dysfunction correlating with disease severity. Focal hypoechogenicity, associated with baseline high FT4, IL6 and low TSH, does not seem to be related to thyroid autoimmunity and may persist after 1 year although decreasing in size. Long-term consequences seem unlikely. Bioscientifica Ltd 2023-01-30 /pmc/articles/PMC10083670/ /pubmed/36715690 http://dx.doi.org/10.1530/ETJ-22-0200 Text en © the author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Research Muller, Ilaria Daturi, Anita Varallo, Matteo Re, Tiziana E Dazzi, Davide Maioli, Sara Crivicich, Erica Di Marco, Francesco Longari, Virgilio Dazzi, Beatrice Castellani, Massimo Mantovani, Giovanna Arosio, Maura Salvi, Mario Long-term outcome of thyroid abnormalities in patients with severe Covid-19 |
title | Long-term outcome of thyroid abnormalities in patients with severe Covid-19 |
title_full | Long-term outcome of thyroid abnormalities in patients with severe Covid-19 |
title_fullStr | Long-term outcome of thyroid abnormalities in patients with severe Covid-19 |
title_full_unstemmed | Long-term outcome of thyroid abnormalities in patients with severe Covid-19 |
title_short | Long-term outcome of thyroid abnormalities in patients with severe Covid-19 |
title_sort | long-term outcome of thyroid abnormalities in patients with severe covid-19 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083670/ https://www.ncbi.nlm.nih.gov/pubmed/36715690 http://dx.doi.org/10.1530/ETJ-22-0200 |
work_keys_str_mv | AT mullerilaria longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19 AT daturianita longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19 AT varallomatteo longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19 AT retizianae longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19 AT dazzidavide longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19 AT maiolisara longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19 AT crivicicherica longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19 AT dimarcofrancesco longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19 AT longarivirgilio longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19 AT dazzibeatrice longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19 AT castellanimassimo longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19 AT mantovanigiovanna longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19 AT arosiomaura longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19 AT salvimario longtermoutcomeofthyroidabnormalitiesinpatientswithseverecovid19 |